| Drug | Indications | Adult Dosage & Administration | Precautions | 
  | Atropine sulfate | First-line therapy for symptomatic bradycardia   Second-line therapy for asystole or bradycardic pulseless electrical activity (after epinepherine) | For asystole or PEA - 1 mg IVP; may repeat every 3 - 5 minutes to maximum dose of 0.03 - 0.04 mg/kg   For bradycardia - 0.05 - 1 mg IVP; may repeat every 3 - 5 minutes to maximum dose of 0.03 - 0.04 mg/kg  Endotracheal administration - 2 - 3 mg diluted in 10 ml NS |    | Use cautiously in patients with myocardial ischemia and/or hypoxia; increases myocardial oxygen demand.    |   | Avoid in hypothermic patients. |  
 | 
  | Calcium Chloride | Hyperkalemia   Hypocalcemia  Antidote for overdose of calcium channel blocker | 8-16 mg/kg IV slowly |    | Not routinely used for cardiac arrest.    |   | Do not mix with sodium bicarbonate. |  
 | 
  | Digoxin | To slow ventricular response in atrial fibrillation or atrial flutter   PSVT refractory to other therapy (i.e. vagal maneuvers, adenosine, diltiazem, verapamil) | Loading dose: 10-15 mcg/kg given over at least 5 minutes;      Maintenance dose: affected by body size & renal function |    | Toxic effects are common & may precipitate arrhythmias.    |   | Avoid electrical cardioversion (and lower current settings) for patients receiving digoxin.    |   | Antidote = digibind. |  
 | 
  | Dobutamine | CHF or pulmonary congestion with hypotension | 2-20 mcg/kg/minute titrated so that heart rate doesn't exceed 10% of baseline     (amp. 250mg/5ml) |    | May cause tachyarrhythmias, fluctuations in BP.    |   | Cardiac & hemodynamic monitoring is recommended. |  
 | 
  | Dopamine | Hypotension with signs & symptoms of shock   Symptomatic bradycardia (after atropine) | Low (renal) dose - 1-5 mcg/kg/minute   Moderate - 5-10 mcg/kg/minute  High - 10-20 mcg/kg/minute  (amp. 200mg/5ml) |    | Use only after volume replacement in hypovolemic patient.    |   | May cause tachyarrhythmias, excessive vasoconstriction.    |   | Avoid extravasation administer phentolamine SQ in area of extravasation to minimize tissue necrosis. |  
 | 
  | Epinepherine | Ventricular fibrillation, pulseless ventricular tachycardia, asystole, pulseless electrical activity   Symptomatic bradycardia after atropine & transcutaneous pacing  Severe allergic reactions, anaphylaxis | Cardiac arrest - 1.0 mg IVP; may repeat q 3-5 minutes   Endotracheal administration - 2.0-2.5 mg diluted in 10 ml. NS  Profound bradycardia - 2-10 mcg/minute     |    | If administration causes rapid, marked rise in BP, can see aortic rupture, cerebral hemorrhage, or angina pectoris.    |   | ADMINISTRATION OF SC PREPARATION BY IV ROUTE MAY CAUSE SEVERE OR FATAL HYPERTENSION OR CEREBROVASCULAR HEMORRHAGE. |  
 | 
  | Furosemide | Acute pulmonary edema without signs/symptoms of shock   Hypertensive emergencies  Increased intracranial pressure | 0.5-1.0 mg/kg IV over 1-2 minutes; if no response, may double the dose to 1.0 mg/kg IV over 1-2 minutes |    | Monitor serum electrolytes.    |   | May cause dehydration, hypovolemia, hypotension, & electrolyte imbalance. |  
 | 
  | Magnesium sulfate | Cardiac arrest related to torsades de pointes or low serum magnesium   VF refractory to lidocaine & bretylium  Torsades de pointes with a pulse  Ventricular arrhythmias associated with digitalis toxicity or tricyclic overdose  Resistant BS | Cardiac arrest -1-2 Gm IVP   Acute myocardial infarction -1-2 Gm. diluted in 50-100 ml 5% dextrose in water IV over 5-60 minutes; follow with 0.5-1.0 Gm/hour IV for up to 24 hours  Torsades de pointes -1-2 Gm. diluted in 50-100 ml 5% dextrose in water IV over 5-60 minutes; follow with 1-4 Gm/hour IV titrated to control the torsades |    | Rapid IV administration may cause hypotension.    |   | Use with caution in patient with renal disease.    |   | May cause respiratory failure.  Do not administer if patient has absent patellar reflexes, respiratory depression, or oliguria.     |  Causes hypotonia. | 
  | Morphine sulfate | Chest pain & anxiety associated with acute MI or cardiac ischemia   Acute cardiogenic pulmonary edema | 1-3 mg IV over 1-5 minutes; may repeat every 5-30 minutes |    | Use cautiously in patients with respiratory compromise.    |   | May cause hypotension in patients with hypovolemia.    |   | Antidote: naloxone 0.4-2.0 mg IV. |  
 | 
  | Nitroglycerin | Chest pain of suspected cardiac origin   Unstable angina  Complications of acute myocardial infarction, including CHF & LV failure  Hypertensive crisis | 10-20 mcg/minute infusion titrated to effect   0.3-0.4 mg sublingually every 5 minutes |    | Monitor VS & EKG during therapy.    |   | Use NTG tubing.    |   | Do not mix with other drugs. |  
 | 
  | Norepinepherine | Cardiogenic shock   Hemodynamically significant hypotension | Start at 0.5-1.0 mcg/minute; titrate to 30 mcg/minute  |    | Increases myocardial oxygen requirements and may induce arrhythmias, therefore use cautiously in patient with cardiac ischemia.    |   | Extravasation causes tissue necrosis. |  
 | 
  | Sodium Bicarbonate | Known preexisting hyperkalemia   Known preexisting bicarbonate-responsive acidosis  Overdosage of tricyclic antidepressants or aspirin  May be used in prolonged resuscitation with effective ventilation or upon return of spontaneous circulation after long arrest | Initial dose: 1 mEq/kg IV bolus   Repeat half of initial dose every 10 minutes thereafter  Given dose:  1/6BWt.x deficit |    | ABG analysis of pH, pCO2, and base deficit is helpful in guiding bicarbonate therapy.    |   | Harmful in hypoxic lactic acidosis, i.e. cardiac arrest & CPR without intubation/adequate ventilation. |  
 | 
  | Sodium Nitroprusside | Hypertensive crisis   To reduce afterload in heart failure, acute pulmonary edema, or acute mitral or aortic valve regurgitation | Begin at 0.10 mcg/kg/minute and titrate upward every 3-5 minutes to desired effect (up to 5.0 mcg/kg/minute) |    | Drug is light-sensitive; therefore, wrap drug reservoir in aluminum foil.    |   | May cause thiocyanate toxicity: blurred vision, tinnitis, confusion, hyperreflexia, seizures.    |   | Use with an infusion pump; closely monitor blood pressure during therapy. |  
 | 
  | Verapamil | PSVT with narrow QRS complex & adequate blood pressure | 2.5-5.0 mg bolus over 1-2 minutes; may administer 5-10 mg if needed 15-30 minutes after initial dose   Maximum dose = 30 mg. |    | Expect BP to drop   due to peripheral vasodilation.    |   | IV calcium can   restore BP; some clinicians recommend administering ca prophylactically   prior to Verapamil. |  
 | 
  | Heparin / Cal-heparin | Prophylaxis and treatment of PE  AF with embolization  Diagnosis and treatment of DIC  Prevention of clotting in arterial and cardiac surgery  Prophylaxis and treatment of peripheral arterial embolism.  In blood transfusions, extracorporeal circulation, and dialysis procedures and in blood samples | Loading dose: 80 IU/Kg     Maintenance dose:   18 IU/Kg/hr IV     Prophylactic dose:  5000 IU/12hrs Sc    | Follow up with PTT aiming to become double normal.     Regular platelet count monitoring.     Antidote= protamine sulphate (1mg neutralizes 1mg heparin or 100 unit)      Not used in bleeding tendencies or recent stroke or active PU.    | 
  | Clexane | PE     DVT     MI     Unstable angina     In dialysis machine | Prophylactic dose: 1mg/Kg/d Sc/IV     Therapeutic dose: 1mg/Kg/12hrs Sc/IV | Low molecular weight heparin (enoxaparin or fraxiparin).     FU renal function, K+ and platelets.       | 
  | Aminophylline | Acute severe asthma     COPD exacerbation     P. edema     Increase diaphragmatic motility | Loading dose: 6mg/Kg/20mins     Maintenance dose:  0.6mg/Kg/hr IV slowly | Slowly IV diluted in fluids.     Monitoring dose for side effects and drug interactions.    | 
  | Trichium | Muscle relaxant after ventilation (neuromuscular blocker). | Initial dose: 2.5-3 mcg/kg/min      Infusion: 0.1-2 mg/kg     (amp. 25mg/2.5ml or 50mg/5ml) | Caution with hypotension and hypotonia. | 
  | Midazolam (Dormicum)    | Procedural sedation     Pre-operative     Acute aggression or delirium     Status epilepticus     After MV | Loading dose: 0.02-0.1 mg/Kg (as valium)     Maintenance dose: 0.04-0.2 mg/Kg/hr     1ml, 3ml, 10ml amp. With conc. 5mg/ml and  Oral form 7.5mg tab. | Relative contraindications in hypotension, hypersensitivity, glaucoma and drug interactions.     Fastest onset, shortest duration. | 
  | Doxapram (Dopram) | Stimulate respiration in:     Post-anesthesia     Drug induced CNS depression     Chronic pulmonary disease with hypercapnea       | IV: 0.5-1 mg/Kg single injection with 5 min interval, maximum 2 mg/Kg     Infusion: 1-3 mg/min, maximum 300 mg/d     (400mg amp.) | Not with epilepsy, PE, cerebral injuries or ischemia, mechanical disorders of ventilation, severe hypertension.     Slow infusion to prevent hemolysis, seizures.     Monitor ECG. | 
 
1 comment:
Gazaky allah kol kheer ya a7la Chestaweya fel donya..;)
May allah bless u isa..
Post a Comment